Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production base in Beijing, which will ...

Sanofi SA will invest around 1 billion euros ($1.1 billion) to build a new insulin production base in Beijing, its biggest ...

The new base, which will be located in Yizhuang, Beijing, marks Sanofi’s second production site in the capital and its fourth ...

French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 ...

"I think we were contrarians,” Sanofi's chief digital officer Emmanuel Frenehard told Fortune. “I think the contrarians are ...

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Shortly after a similarly sized venture from Pfizer, French pharma juggernaut Sanofi has unveiled a major manufacturing ...

JPMorgan raised the firm’s price target on Sanofi (SNY) to EUR 105 from EUR 100 and keeps a Neutral rating on the shares.Don't Miss our Black ...

Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...